semaglutide ckd without diabetes just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Examining the Safety and Efficacy

The line-up also contains a heavy protein powder that also contains collagen, as skin health is a recurring issue for people taking GLP-1s

and Zepbound (tirzepatide), which was approved in 2023 (it was previously available to treat diabetes under the brand name Mounjaro)

Es importante sealar que Ozempic est aprobado por la FDA especficamente para el tratamiento de la diabetes tipo 2 y su uso para el manejo del peso sera considerado fuera de etiqueta en los Estados Unidos

You may be able to reduce your dosing to 3 times weekly as you reach a steady state and your goals

ProALCAR+ Plus GBB is intended only for adults over 18. Consult a licensed health-care practitioner before use